Clinical Trials
Etentamig + D vs Daratumumab, Lenalidomide, & Dexamethasone in patients with newly diagnosed MM
Disease Type: Myelomas
A Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville